Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgical Navigation System for SLN Detection in Early Breast Cancer
NCT02084784Completed
- Sponsor
- Chinese Academy of Sciences
- Start
- Jan 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in breast cancer, sponsored by Chinese Academy of Sciences. Primary endpoint: Sentinel lymph node detection rate at 1 year. Started Jan 2014; status: completed.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02084784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084784.